The effect of diabetes on the diagnostic and prognostic performance of mid-region pro-atrial natriuretic peptide and mid-region pro-adrenomedullin in patients with acute dyspnea

References

• Bell GM, Bernstein RK, Laragh JH, Atlas SA, James GD, Pecker MS, Sealey JE. (1989). Increased plasma atrial natriuretic factor and reduced plasma renin in patients with poorly controlled diabetes mellitus. Clin Sci 77:177–182.
   Web of Science ®Google Scholar
• Cockcroft DW, Gault MH. (1976). Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41.
   PubMed Web of Science ®Google Scholar
• Eto T. (2001). A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. Peptides 22:1693–1711.
   PubMed Web of Science ®Google Scholar
• Daniels LB, Clopton P, Bhalla V, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA, Maisel AS. (2006). How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study. Am Heart J 151:999–1005.
   PubMed Web of Science ®Google Scholar
• Daniels LB, Clopton P, Potocki M, Mueller C, McCord J, Richards M, Hartmann O, Wu AHB, Nowak R, Peacock WF, Ponikowski P, Moeckel M, Hogan C, Filippatos GS, Di Somma S, Ander I, Ng L, Neath SN, Christenson R, Morgenthaler NG, Anker SD, Maisel AS. (2011). Influence of age, race, sex and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH Multinational Study. 2011, Eur J Heart Failure Epub ahead of print. doi:10.1093/eurjhfr157.
   PubMed Web of Science ®Google Scholar
• Hayashi M, Shimosawa T, Isaka M, Yamada S, Fujita R, Fujita T. (1997). Plasma adrenomedullin in diabetes. Lancet 350:1449–1450.
   PubMed Web of Science ®Google Scholar
• Hayashi M, Shimosawa T, Fujita T. (1999). Hyperglycemia increases vascular adrenomedullin expression. Biochem Biophys Res Commun 258:453–456.
   PubMed Web of Science ®Google Scholar
• Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T. (1994). Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 338:6–10.
   PubMed Web of Science ®Google Scholar
• Januzzi JL Jr., Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, Tung R, Cameron R, Nagurney JT, Chae CU, Lloyd-Jones DM, Brown DF, Foran-Melanson S, Sluss PM, Lee-Lewandrowski E, Lewandrowski KB. (2005). The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95:948–954.
   PubMed Web of Science ®Google Scholar
• Katsuki A, Sumida Y, Gabazza EC, Murashima S, Urakawa H, Morioka K, Kitagawa N, Tanaka T, Araki-Sasaki R, Hori Y, Nakatani K, Yano Y, Adachi Y. (2002). Acute hyperinsulinemia is associated with increased circulating levels of adrenomedullin in patients with type 2 diabetes mellitus. Eur J Endocrinol 147:71–75.
   PubMed Web of Science ®Google Scholar
• Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Maruyama N, Morioka K, Kitagawa N, Hori Y, Nakatani K, Yano Y, Adachi Y. (2003). Increased oxidative stress is associated with elevated plasma levels of adrenomedullin in hypertensive patients with type 2 diabetes. Diabetes Care 26:1642–1643.
   PubMed Web of Science ®Google Scholar
• Kinoshita H, Kato K, Kuroki M, Nakamura S, Kitamura K, Hisanaga S, Fujimoto S, Eto T. (2000). Plasma adrenomedullin levels in patients with diabetes. Diabetes Care 23:253–254.
   PubMedGoogle Scholar
• Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA; Breathing Not Properly Multinational Study Investigators. (2002). Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161–167.
   PubMed Web of Science ®Google Scholar
• Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng L, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, von Haehling S, Bergmann A, Morgenthaler NG, Anker SD. (2010). Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 55:2062–2076.
   PubMed Web of Science ®Google Scholar
• Martínez A, Elsasser TH, Bhathena SJ, Pío R, Buchanan TA, Macri CJ, Cuttitta F. (1999). Is adrenomedullin a causal agent in some cases of type 2 diabetes? Peptides 20:1471–1478.
   PubMed Web of Science ®Google Scholar
• McCullough PA, Duc P, Omland T, McCord J, Nowak RM, Hollander JE, Herrmann HC, Steg PG, Westheim A, Knudsen CW, Storrow AB, Abraham WT, Lamba S, Wu AH, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS; Breathing Not Properly Multinational Study Investigators. (2003). B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 41:571–579.
   PubMed Web of Science ®Google Scholar
• McKenna K, Smith D, Tormey W, Thompson CJ. (2000). Acute hyperglycaemia causes elevation in plasma atrial natriuretic peptide concentrations in Type 1 diabetes mellitus. Diabet Med 17:512–517.
   PubMed Web of Science ®Google Scholar
• McKnight JA, Roberts G, Sheridan B, Bell PM, Atkinson AB. (1991). Basal and stimulated plasma atrial natriuretic factor in patients with type 1 diabetes with and without nephropathy. Diabet Med 8:765–769.
   PubMed Web of Science ®Google Scholar
• Mogensen CE, Christensen CK. (1984). Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89–93.
   PubMed Web of Science ®Google Scholar
• Morgenthaler NG, Struck J, Thomas B, Bergmann A. (2004). Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clin Chem 50:234–236.
   PubMed Web of Science ®Google Scholar
• Morgenthaler NG, Struck J, Alonso C, Bergmann A. (2005). Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 51:1823–1829.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Honda K, Ishikawa S, Kitamura K, Eto T, Saito T. (1998). Plasma adrenomedullin levels in patients with non-insulin dependent diabetes mellitus: close relationships with diabetic complications. Endocr J 45:241–246.
   PubMed Web of Science ®Google Scholar
• Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, Eto T, Matsuo H. (1994). Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 201:1160–1166.
   PubMed Web of Science ®Google Scholar
• Vanderheyden M, Bartunek J, Goethals M. (2004). Brain and other natriuretic peptides: molecular aspects. Eur J Heart Fail 6:261–268.
   PubMed Web of Science ®Google Scholar
• Wieczorek SJ, Wu AH, Christenson R, Krishnaswamy P, Gottlieb S, Rosano T, Hager D, Gardetto N, Chiu A, Bailly KR, Maisel A. (2002). A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J 144:834–839.
   PubMed Web of Science ®Google Scholar
• Wu AH, Omland T, Duc P, McCord J, Nowak RM, Hollander JE, Herrmann HC, Steg PG, Wold Knudsen C, Storrow AB, Abraham WT, Perez A, Kamin R, Clopton P, Maisel AS, McCullough PA; Breathing Not Properly Multinational Study Investigators. (2004). The effect of diabetes on B-type natriuretic peptide concentrations in patients with acute dyspnea: an analysis from the Breathing Not Properly Multinational Study. Diabetes Care 27:2398–2404.
   PubMed Web of Science ®Google Scholar
• Wu AH, Omland T, Wold Knudsen C, McCord J, Nowak RM, Hollander JE, Duc P, Storrow AB, Abraham WT, Clopton P, Maisel AS, McCullough PA; Breathing Not Properly Multinational Study Investigations. (2005). Relationship of B-type natriuretic peptide and anemia in patients with and without heart failure: a substudy from the Breathing Not Properly (BNP) Multinational Study. Am J Hematol 80:174–180.
   PubMed Web of Science ®Google Scholar
• Zietse R, Derkx FH, Weimar W, Schalekamp MA. (1995). Effect of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus. J Am Soc Nephrol 5:2057–2066.
   PubMed Web of Science ®Google Scholar